
Profitability, historical returns, and peer comparisons.
According to BriaCell Therapeutics Corp.’s latest financial reports and current stock price. The company's current ROE is -170.70%. This represents a change of 226.24% compared to the average of -52.32% of the last 4 quarters.
The mean historical ROE of BriaCell Therapeutics Corp. over the last ten years is 7.64%. The current -170.70% ROE has changed -2332.92% with respect to the historical average. Over the past ten years (40 quarters), BCTXW's ROE was at its highest in in the January 2023 quarter at 937.72%. The ROE was at its lowest in in the October 2018 quarter at -220.71%.
Average
7.64%
Median
-99.19%
Minimum
-439.59%
Maximum
684.25%
Discovering the peaks and valleys of BriaCell Therapeutics Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 420.42%
Maximum Annual ROE = 684.25%
Minimum Annual Increase = -306.86%
Minimum Annual ROE = -439.59%
| Year | ROE | Change |
|---|---|---|
| 2026 | -216.04% | 45.54% |
| 2025 | -148.44% | -173.81% |
| 2024 | 201.12% | -62.58% |
| 2023 | 537.50% | -306.86% |
| 2022 | -259.84% | 420.42% |
| 2021 | -49.93% | -144.63% |
| 2020 | 111.87% | -83.65% |
| 2019 | 684.25% | -255.65% |
| 2018 | -439.59% | 27.62% |
| 2017 | -344.44% | 59.89% |
The current ROE of BriaCell Therapeutics Corp. (BCTXW) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-54.45%
5-year avg
22.86%
10-year avg
7.64%
BriaCell Therapeutics Corp.’s ROE is less than Ocean Biomedical, Inc. (3.50%), greater than SAB Biotherapeutics, Inc. (-6.74%), greater than Nuwellis, Inc. (-605.75%), less than Peak Bio, Inc. (0.01%), greater than Vincerx Pharma, Inc. (-431.29%), greater than PetVivo Holdings, Inc. (-351.76%), greater than Lixte Biotechnology Holdings, Inc. (-74.82%), greater than Syros Pharmaceuticals, Inc. (-227.94%), greater than Pasithea Therapeutics Corp. (-49.49%), less than Celularity Inc. (142.25%),
| Company | ROE | Market cap |
|---|---|---|
| 3.50% | $118.63K | |
| -6.74% | $301.16M | |
| -605.75% | $502.96K | |
| 0.01% | $520.31K | |
| -431.29% | $78.51K | |
| -351.76% | $24.27M | |
| -74.82% | $89.11M | |
| -227.94% | $10.73K | |
| -49.49% | $12.37M | |
| 142.25% | $26.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BriaCell Therapeutics Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BriaCell Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BriaCell Therapeutics Corp.'s ROE?
How is the ROE calculated for BriaCell Therapeutics Corp. (BCTXW)?
What is the highest ROE for BriaCell Therapeutics Corp. (BCTXW)?
What is the 3-year average ROE for BriaCell Therapeutics Corp. (BCTXW)?
What is the 5-year average ROE for BriaCell Therapeutics Corp. (BCTXW)?
How does the current ROE for BriaCell Therapeutics Corp. (BCTXW) compare to its historical average?